SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Maria Teresa Catanese, Marcus Dorner, Advances in experimental systems to study hepatitis C virus in vitro and in vivo, Virology, 2015, 479-480, 221

    CrossRef

  2. 2
    Leopold Kong, Kelli N Jackson, Ian A Wilson, Mansun Law, Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design, Current Opinion in Virology, 2015, 11, 148

    CrossRef

  3. 3
    Abdulrahim R. Hakami, Jonathan K. Ball, Alexander W. Tarr, Non-ionic detergents facilitate non-specific binding of M13 bacteriophage to polystyrene surfaces, Journal of Virological Methods, 2015, 221, 1

    CrossRef

  4. 4
    Thomas F. Baumert, Catherine Fauvelle, Diana Y. Chen, Georg M. Lauer, A prophylactic hepatitis C virus vaccine: A distant peak still worth climbing, Journal of Hepatology, 2014, 61, 1, S34

    CrossRef

  5. 5
    Lucie Fénéant, Shoshana Levy, Laurence Cocquerel, CD81 and Hepatitis C Virus (HCV) Infection, Viruses, 2014, 6, 2, 535

    CrossRef

  6. 6
    Heidi E. Drummer, Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies, Frontiers in Microbiology, 2014, 5,

    CrossRef

  7. 7
    Kayla A. Holder, Rodney S. Russell, Michael D. Grant, Natural Killer Cell Function and Dysfunction in Hepatitis C Virus Infection, BioMed Research International, 2014, 2014, 1

    CrossRef

  8. 8
    Siobhán B. Cashman, Brian D. Marsden, Lynn B. Dustin, The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development, Frontiers in Immunology, 2014, 5,

    CrossRef

  9. 9
    Jonathan K. Ball, Alexander W. Tarr, Jane A. McKeating, The past, present and future of neutralizing antibodies for hepatitis C virus, Antiviral Research, 2014, 105, 100

    CrossRef

  10. 10
    Alexander W. Tarr, Pierre Lafaye, Luke Meredith, Laurence Damier-Piolle, Richard A. Urbanowicz, Annalisa Meola, Jean-Luc Jestin, Richard J. P. Brown, Jane A. McKeating, Felix A. Rey, Jonathan K. Ball, Thomas Krey, An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission, Hepatology, 2013, 58, 3
  11. 11
    Nicola Clementi, Nicasio Mancini, Matteo Castelli, Massimo Clementi, Roberto Burioni, Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools, Drug Discovery Today, 2013, 18, 9-10, 464

    CrossRef

  12. 12
    Giuseppe Sautto, Alexander W. Tarr, Nicasio Mancini, Massimo Clementi, Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  13. 13
    Catherine Fallecker, Nicolas Tarbouriech, Mohammed Habib, Marie-Anne Petit, Emmanuel Drouet, Structural and functional characterization of the single-chain Fv fragment from a unique HCV E1E2-specific monoclonal antibody, FEBS Letters, 2013, 587, 20, 3335

    CrossRef

  14. 14
    A. Wahid, J. Dubuisson, Virus-neutralizing antibodies to hepatitis C virus, Journal of Viral Hepatitis, 2013, 20, 6
  15. 15
    Mikiko Sasayama, Ikuo Shoji, Myrna Adianti, Da-Peng Jiang, Lin Deng, Takafumi Saito, Hisayoshi Watanabe, Sumio Kawata, Chie Aoki, Hak Hotta, A point mutation at Asn-534 that disrupts a conserved N-glycosylation motif of the E2 glycoprotein of hepatitis C virus markedly enhances the sensitivity to antibody neutralization, Journal of Medical Virology, 2012, 84, 2
  16. 16
    Giuseppe Sautto, Nicasio Mancini, Roberta A. Diotti, Laura Solforosi, Massimo Clementi, Roberto Burioni, Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference, Antiviral Research, 2012, 96, 1, 82

    CrossRef

  17. 17
    Michelle C. Sabo, Vincent C. Luca, Stuart C. Ray, Jens Bukh, Daved H. Fremont, Michael S. Diamond, Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature, Virology, 2012, 422, 2, 174

    CrossRef

  18. 18
    V. C. Edwards, A. W. Tarr, R. A. Urbanowicz, J. K. Ball, The role of neutralizing antibodies in hepatitis C virus infection, Journal of General Virology, 2012, 93, 1, 1

    CrossRef

  19. 19
    G. Vieyres, J. Dubuisson, A. H. Patel, Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein, Journal of General Virology, 2011, 92, 3, 494

    CrossRef

  20. 20
    Allan GN Angus, Arvind H Patel, Immunotherapeutic potential of neutralizing antibodies targeting conserved regions of the HCV envelope glycoprotein E2, Future Microbiology, 2011, 6, 3, 279

    CrossRef

  21. 21
    Alla Kachko, Galina Kochneva, Galina Sivolobova, Antonina Grazhdantseva, Tatyana Lupan, Iryna Zubkova, Frances Wells, Michael Merchlinsky, Ollie Williams, Hisayoshi Watanabe, Alla Ivanova, Aleksander Shvalov, Valeriy Loktev, Sergei Netesov, Marian E. Major, New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles, Vaccine, 2011, 30, 1, 69

    CrossRef

  22. 22
    Jie Cao, Zhihui Chen, Yanli Ren, Yuan Luo, Mingmei Cao, Wei Lu, Ping Zhao, Zhongtian Qi, Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice, Vaccine, 2011, 29, 20, 3714

    CrossRef

  23. 23
    Daisuke Akazawa, Kenichi Morikawa, Noriaki Omi, Hitoshi Takahashi, Noriko Nakamura, Hidenori Mochizuki, Tomoko Date, Koji Ishii, Tetsuro Suzuki, Takaji Wakita, Production and characterization of HCV particles from serum-free culture, Vaccine, 2011, 29, 29-30, 4821

    CrossRef

  24. 24
    Joseph Torresi, Doug Johnson, Heiner Wedemeyer, Progress in the development of preventive and therapeutic vaccines for hepatitis C virus, Journal of Hepatology, 2011, 54, 6, 1273

    CrossRef

  25. 25
    Ndiémé Ndongo, Pascale Berthillon, Pierre Pradat, Claude Vieux, Isabelle Bordes, Françoise Berby, Marianne Maynard, Fabien Zoulim, Christian Trépo, Marie-Anne Petit, Association of anti-E1E2 antibodies with spontaneous recovery or sustained viral response to therapy in patients infected with hepatitis C virus, Hepatology, 2010, 52, 5
  26. 26
    Erika A. Eksioglu, Jennifer Bess, Graham Jones, Jennifer Dettloff, Parinda Dangmeon, Hui-Jia Dong, Haizhen Zhu, Roberto Firpi, Yiling Xu, David R. Nelson, Chen Liu, Characterization of Anti-HCV Antibodies in IL-10-Treated Patients, Viral Immunology, 2010, 23, 4, 359

    CrossRef

  27. 27
    Kristelle S. Brown, Michael J. Keogh, Ania M. Owsianka, Richard Adair, Arvind H. Patel, James N. Arnold, Jonathan K. Ball, Robert B. Sim, Alexander W. Tarr, Timothy P. Hickling, Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry, Protein & Cell, 2010, 1, 7, 664

    CrossRef

  28. 28
    S. Fafi-Kremer, I. Fofana, E. Soulier, P. Carolla, P. Meuleman, G. Leroux-Roels, A. H. Patel, F.-L. Cosset, P. Pessaux, M. Doffoel, P. Wolf, F. Stoll-Keller, T. F. Baumert, Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation, Journal of Experimental Medicine, 2010, 207, 9, 2019

    CrossRef

  29. 29
    Christopher M. Walker, 2010,

    CrossRef

  30. 30
    J. Witteveldt, M. J. Evans, J. Bitzegeio, G. Koutsoudakis, A. M. Owsianka, A. G. N. Angus, Z.-Y. Keck, S. K. H. Foung, T. Pietschmann, C. M. Rice, A. H. Patel, CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells, Journal of General Virology, 2009, 90, 1, 48

    CrossRef

  31. 31
    P. Zhang, L. Zhong, E. B. Struble, H. Watanabe, A. Kachko, K. Mihalik, M. L. Virata-Theimer, H. J. Alter, S. Feinstone, M. Major, Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity, Proceedings of the National Academy of Sciences, 2009, 106, 18, 7537

    CrossRef

  32. 32
    R. Adair, A. H. Patel, L. Corless, S. Griffin, D. J. Rowlands, C. J. McCormick, Expression of hepatitis C virus (HCV) structural proteins in trans facilitates encapsidation and transmission of HCV subgenomic RNA, Journal of General Virology, 2009, 90, 4, 833

    CrossRef

  33. 33
    Ndiémé Ndongo, Yassine Rechoum, Sylvie De Sequeira, Fabien Zoulim, Christian Trépo, Emmanuel Drouet, Marie-Anne Petit, Inhibition of the binding of HCV serum particles to human hepatocytes by E1E2-specific D32.10 monoclonal antibody, Journal of Medical Virology, 2009, 81, 10
  34. 34
    Marian E. Major, Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives, Viruses, 2009, 1, 2, 144

    CrossRef

  35. 35
    S. Fafi-Kremer, M.B. Zeisel, E. Schvoerer, E. Soulier, F. Habersetzer, P. Wolf, M. Doffoel, T.F. Baumert, F. Stoll-Keller, Anticorps neutralisants dirigés contre le virus de l’hépatite C, Gastroentérologie Clinique et Biologique, 2008, 32, 5, 491

    CrossRef

  36. 36
    M. R. B. Hamed, A. W. Tarr, C. P. McClure, J. K. Ball, T. P. Hickling, W. L. Irving, Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease, Journal of Viral Hepatitis, 2008, 15, 5
  37. 37
    Mansun Law, Toshiaki Maruyama, Jamie Lewis, Erick Giang, Alexander W Tarr, Zania Stamataki, Pablo Gastaminza, Francis V Chisari, Ian M Jones, Robert I Fox, Jonathan K Ball, Jane A McKeating, Norman M Kneteman, Dennis R Burton, Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge, Nature Medicine, 2008, 14, 1, 25

    CrossRef

  38. 38
    Frédéric Schramm, Eric Soulier, Cathy Royer, Thierry Weitten, Samira Fafi-Kremer, Nicolas Brignon, Nicolas Meyer, Bernard Ellero, Marie-Lorraine Woehl-Jaegle, Carole Meyer, Philippe Wolf, Michel Doffoël, Thomas F. Baumert, Françoise Stoll-Keller, Evelyne Schvoerer, Frequent Compartmentalization of Hepatitis C Virus with Leukocyte-Related Amino Acids in the Setting of Liver Transplantation, The Journal of Infectious Diseases, 2008, 198, 11, 1656

    CrossRef

  39. 39
    M. Gal-Tanamy, Z.-Y. Keck, M. Yi, J. A. McKeating, A. H. Patel, S. K. H. Foung, S. M. Lemon, In vitro selection of a neutralization-resistant hepatitis C virus escape mutant, Proceedings of the National Academy of Sciences, 2008, 105, 49, 19450

    CrossRef

  40. 40
    Judith M. Gottwein, Jens Bukh, 2008,

    CrossRef

  41. 41
    Yu-Ching Lee, Sy-Jye C. Leu, Han-Chang Hung, Hsueh-Hsia Wu, I.-Jen Huang, Wen-Shyang Hsieh, Wen-Ta Chiu, Ming-Song Hsieh, Tsui-Fen Cheng, Yi-Yuan Yang, A dominant antigenic epitope on SARS-CoV spike protein identified by an avian single-chain variable fragment (scFv)-expressing phage, Veterinary Immunology and Immunopathology, 2007, 117, 1-2, 75

    CrossRef

  42. 42
    Joseph Torresi, Owen M. Stock, Alexandra E. Fischer, Lara Grollo, Heidi Drummer, Irene Boo, Weiguang Zeng, Linda Earnest-Silveira, David C. Jackson, A self-adjuvanting multiepitope immunogen that induces a broadly cross-reactive antibody to hepatitis C virus, Hepatology, 2007, 45, 4
  43. 43
    Ashraf A. Tabll, Samy B. Khalil, Reem M. El-Shenawy, Gamal Esmat, Amr Helmy, Abdel Fattah Attallah, Mostafa K. El-Awady, Establishment of Hybrid Cell Lines Producing Monoclonal Antibodies to a Synthetic Peptide from the E1 Region of the Hepatitis C Virus, Journal of Immunoassay and Immunochemistry, 2007, 29, 1, 91

    CrossRef

  44. 44
    Zania Stamataki, Stephen Coates, Matthew J. Evans, Mark Wininger, Kevin Crawford, Christine Dong, Yiu-lian Fong, David Chien, Sergio Abrignani, Peter Balfe, Charles M. Rice, Jane A. McKeating, Michael Houghton, Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies, Vaccine, 2007, 25, 45, 7773

    CrossRef

  45. 45
    P. Zhang, C. G. Wu, K. Mihalik, M. L. Virata-Theimer, M.-y. W. Yu, H. J. Alter, S. M. Feinstone, Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma, Proceedings of the National Academy of Sciences, 2007, 104, 20, 8449

    CrossRef

  46. 46
    Joseph Torresi, Alex Fischer, Lara Grollo, Weiguang Zeng, Heidi Drummer, David C Jackson, Induction of neutralizing antibody responses to hepatitis C virus with synthetic peptide constructs incorporating both antibody and T-helper epitopes, Immunology and Cell Biology, 2007, 85, 2, 169

    CrossRef

  47. 47
    Bo Jin, Richard Y. Wang, Qi Qiu, Fuminaka Sugauchi, Teresa Grandinetti, Harvey J. Alter, J. Wai-Kuo Shih, Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA, Immunology, 2007, 122, 1
  48. 48
    M. Dreux, F.-L. Cosset, The scavenger receptor BI and its ligand, HDL: partners in crime against HCV neutralizing antibodies, Journal of Viral Hepatitis, 2007, 14,
  49. 49
    Gary L. Davis, Hepatitis C immune globulin to prevent HCV recurrence after liver transplantation: Chasing windmills?, Liver Transplantation, 2006, 12, 9
  50. 50
    Heidi Barth, T. Jake Liang, Thomas F. Baumert, Hepatitis C virus entry: Molecular biology and clinical implications, Hepatology, 2006, 44, 3
  51. 51
    Gary L. Davis, New Therapies: Oral Inhibitors and Immune Modulators, Clinics in Liver Disease, 2006, 10, 4, 867

    CrossRef